Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Jun 18;331(23):1997-2006.
doi: 10.1001/jama.2024.6063.

Krill Oil for Knee Osteoarthritis: A Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Krill Oil for Knee Osteoarthritis: A Randomized Clinical Trial

Laura L Laslett et al. JAMA. .

Abstract

Importance: Knee osteoarthritis is disabling, with few effective treatments. Preliminary evidence suggested that krill oil supplementation improved knee pain, but effects on knee osteoarthritis remain unclear.

Objective: To evaluate efficacy of krill oil supplementation, compared with placebo, on knee pain in people with knee osteoarthritis who have significant knee pain and effusion-synovitis.

Design, setting, and participants: Multicenter, randomized, double-blind, placebo-controlled clinical trial in 5 Australian cities. Participants with clinical knee osteoarthritis, significant knee pain, and effusion-synovitis on magnetic resonance imaging were enrolled from December 2016 to June 2019; final follow-up occurred on February 7, 2020.

Interventions: Participants were randomized to 2 g/d of krill oil (n = 130) or matching placebo (n = 132) for 24 weeks.

Main outcomes and measures: The primary outcome was change in knee pain as assessed by visual analog scale (range, 0-100; 0 indicating least pain; minimum clinically important improvement = 15) over 24 weeks.

Results: Of 262 participants randomized (mean age, 61.6 [SD, 9.6] years; 53% women), 222 (85%) completed the trial. Krill oil did not improve knee pain compared with placebo (mean change in VAS score, -19.9 [krill oil] vs -20.2 [placebo]; between-group mean difference, -0.3; 95% CI, -6.9 to 6.4) over 24 weeks. One or more adverse events was reported by 51% in the krill oil group (67/130) and by 54% in the placebo group (71/132). The most common adverse events were musculoskeletal and connective tissue disorders, which occurred 32 times in the krill oil group and 42 times in the placebo group, including knee pain (n = 10 with krill oil; n = 9 with placebo), lower extremity pain (n = 1 with krill oil; n = 5 with placebo), and hip pain (n = 3 with krill oil; n = 2 with placebo).

Conclusions and relevance: Among people with knee osteoarthritis who have significant knee pain and effusion-synovitis on magnetic resonance imaging, 2 g/d of daily krill oil supplementation did not improve knee pain over 24 weeks compared with placebo. These findings do not support krill oil for treating knee pain in this population.

Trial registration: Australian New Zealand Clinical Trials Registry Identifier: ACTRN12616000726459; Universal Trial Number: U1111-1181-7087.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Cai reported receipt of grants from the National Natural Science Foundation of China. Dr Hill reported receipt of grants from the University of Adelaide. Dr March reported receipt of grants from the Medical Research Future Fund Australia (to institution). Dr Keen reported being an investigator for various pharmaceutical trials and doing paid talks for Roche. No other disclosures were reported.

Similar articles

References

    1. Cross M, Smith E, Hoy D, et al. . The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323-1330. doi:10.1136/annrheumdis-2013-204763 - DOI - PubMed
    1. Conaghan PG, Cook AD, Hamilton JA, Tak PP. Therapeutic options for targeting inflammatory osteoarthritis pain. Nat Rev Rheumatol. 2019;15(6):355-363. doi:10.1038/s41584-019-0221-y - DOI - PubMed
    1. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249-257. doi:10.1016/j.bone.2012.02.012 - DOI - PMC - PubMed
    1. Wang X, Blizzard L, Halliday A, et al. . Association between MRI-detected knee joint regional effusion-synovitis and structural changes in older adults: a cohort study. Ann Rheum Dis. 2016;75(3):519-525. doi:10.1136/annrheumdis-2014-206676 - DOI - PubMed
    1. Laslett LL, Pelletier JP, Cicuttini FM, Jones G, Martel-Pelletier J. Measuring disease progression in osteoarthritis. Curr Treatm Opt Rheumatol. 2016;2(2):97-110. doi:10.1007/s40674-016-0041-z - DOI

Publication types

Supplementary concepts

LinkOut - more resources